Illumina has appointed Rebecca Chambers to senior director of investor relations. She joins the company from Myriad Genetics, where she was director of relations and corporate communications. Previously, she was senior manager of investor relations at Life Technologies. She holds an MBA from Cornell University and a BS in biology from John Carroll University.
Ross Fitzgerald, who is a group leader at the Roslin Institute in the UK, has been named chair in molecular biology at the University of Edinburgh. Fitzgerald's research focuses on using genomic and molecular tools to understand staphylococcal diseases, with the goal of identifying new therapeutic and diagnostic approaches.